Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Leukemia. 2010 Jun 10;24(8):1406–1411. doi: 10.1038/leu.2010.129

Figure 1.

Figure 1

Treatment schema.

Italicized numbers represent actual numbers of patients progressing through each step.

* Induction cycle: bortezomib 1.3 mg/m2 days 1, 4, 8, & 11 (21 day cycle)

† Maintenance cycle: bortezomib 1.3 mg/m2 days 1 & 15 (28 day cycle)